Organization
Neurocrine Biosciences Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Neurocrine Biosciences Inc.
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the full manuscript of the long-term safety ...
... of which occurred in 2015. The exclusive licensing agreement in 2015 between Neurocrine Biosciences and Mitsubishi Tanabe Pharma to develop and commercialize Neurocrine Biosciences' VMAT2 ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended September ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that data for INGREZZA® (valbenazine) capsules, the first ...
... players which have been significantly contributing to the Women's health market are Neurocrine Biosciences, Gedeon Richter Plc, Ferring Pharmaceuticals, enteris BIOPHARMA, Bayer Healthcare, F. Hoffmann-La ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, CEO of Neurocrine Biosciences, ...
... Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended September ...
... Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, CEO of Neurocrine Biosciences, ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has initiated a Phase IIb clinical ...
... If you want a Stock Review on IRWD, MYL, NBIX, or VSAR then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report third quarter 2017 ...
... Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report third quarter 2017 ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that valbenazine, a novel selective vesicular monoamine transporter ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S. Food and Drug Administration (FDA) ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S. Food and Drug Administration (FDA) ...
... SAN DIEGO - Neurocrine Biosciences Inc. (NASDAQ: NBIX) announced today upcoming poster presentations at the 2017 Annual Psych ...
... If you want a Stock Review on MNK, HZNP, MYL, or NBIX then come over tohttp://dailystocktracker.com/register/and sign up for your free customized report today. ...
... Neurocrine Biosciences Inc. (NASDAQ: NBIX) announced today upcoming poster presentations at the 2017 Annual Psych ...
... Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, CEO of Neurocrine Biosciences, will ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤